Skip to the page

Data / Form D filings / Zura Bio Ltd

Zura Bio Ltd: Form D filings

Zura Bio Ltd, a biotechnology company in Henderson, NV, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on May 6, 2024, reports $112.5 million sold of a $112.5 million offering to 19 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1489 W. Warm Springs Road, Suite 110, Henderson, NV, 89014
Phone
(702) 757-6133
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Cayman Islands
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1855644

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 6, 2024New notice$112,516,087$112,499,985$16,10219Apr 22, 2024sec.gov
May 5, 2023New notice$79,996,220$15,937,500$64,058,72021May 1, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael HowellExecutive Officer
Sandeep KulkarniDirector
Robert LisickiExecutive Officer, Director
Neil GrahamDirector
Kiran NistalaExecutive Officer
Gary WhaleExecutive Officer
Verender BadialExecutive Officer
Steven SchochDirector
Jennifer JarrettDirector
Someit SidhuDirector
Amit MunshiDirector
Kim DavisExecutive Officer
Arnout Ploos van AmstelDirector
Parvinder ThiaraDirector

Other biotechnology companies in Nevada that filed recently

Every Form D from the week of May 6, 2024 · All recent filings in Nevada · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Zura Bio Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.